Spots Global Cancer Trial Database for The Feasibility Study of the Li Brush for the Screening of Endometrial Cancer in the Postmenopausal Period

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: The Feasibility Study of the Li Brush for the Screening of Endometrial Cancer in the Postmenopausal Period

Official Title: The Feasibility Study of Li Brush for the Screening of Endometrial Cancer in the Postmenopausal Period

Study ID: NCT02512848

Conditions

Endometrial Neoplasms

Interventions

Study Description

Brief Summary: Investigators aim to collect endometrial sampling with Li Brush among target population who have risks for endometrial neoplasm, then Fractional curettage should performed with these participants, investigators intend to compare the pathological diagnosis results of cytology and fractional curettage to evaluate the sensitivity of Li Brush and investigators expect that the brush can be used for screening of endometrial cancer in the postmenopausal period in the clinic.

Detailed Description: Investigators screen the suitable participants according to the inclusion and exclusion standards, and then collect their endometrial sampling with Li Brush. Pathologists will help to decide the cytology obtained by Li Brush and histology diagnosis of the endometrial sampling. Comparing the pathological diagnosis results of cytology and histology, investigators want to prove the feasibility of cytology diagnosis of endometrial cancer in the postmenopausal period, as the same time, investigators intend to evaluate the possible factors that affecting the precision of Li Brush for endometrial cancer in the postmenopausal period.